Sunshine Biopharma (SBFMW) Property, Plant & Equipment (Net) Growth (3y) (2018 - 2026)
Sunshine Biopharma (SBFMW) Property, Plant & Equipment (Net) Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | -11.41% |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 8.48% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 27.10% |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 13.12% |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | -27.73% |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 11.74% |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | -11.76% |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 7.32% |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 68.63% |
| 10 | Sunshine Biopharma | - | - | 2.18 Mn | 11.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.95% |
| Dec 31, 2025 | 12.23% |
| Sep 30, 2025 | 441.35% |
| Jun 30, 2025 | 629.84% |
| Mar 31, 2025 | 407.57% |
| Dec 31, 2024 | 326.05% |
| Sep 30, 2024 | 286.51% |
| Jun 30, 2024 | 242.44% |
| Mar 31, 2024 | 189.06% |
| Dec 31, 2023 | 165.58% |
| Sep 30, 2023 | 144.49% |
| Jun 30, 2023 | 140.52% |
| Mar 31, 2023 | 131.50% |
| Dec 31, 2022 | 129.88% |
| Sep 30, 2022 | -52.79% |
| Jun 30, 2022 | -65.07% |
| Mar 31, 2022 | -75.00% |
| Dec 31, 2021 | -46.11% |
| Sep 30, 2021 | -66.82% |
| Jun 30, 2021 | -64.44% |